Podcasts about johns hopkins school

A candid conversation between a professor and a Ph.D. candidate about potential funding cuts from the National Institutes of Health and their impact on the future of medical research.Guests:Yvonne Commodore-Mensah, Associate Professor, Associate Dean of Research, Johns Hopkins School of NursingLaura Mata López, PhD Candidate, Johns Hopkins School of NursingThis episode was produced by Ryan Levi, edited by Dan Gorenstein and mixed by Andrew Parrella and Cedric Wilson.The Tradeoffs theme song was composed by Ty Citerman. Additional music this episode from Blue Dot Sessions and Epidemic Sound.Additional thanks to Rachel Bender Ignacio, Jeremy Berg, Otis Brawley, Aaron Carroll, Dan Cooper, Elena Fuentes-Afflick, Robert Kelchen, Daniel Martinez, Raphe Reggie, Sarah Spreitzer and Sarah Szanton.Reporting for this episode was supported in part by Arnold Ventures.Learn more: Read the full reporting and explore additional resources on our website.Want more Tradeoffs? Join more than 5,500 readers who trust Tradeoffs for clear, deeply reported health policy insights. Sign up for our free weekly newsletter.Tradeoffs helps you cut through the noise with clear, deeply reported journalism on the forces driving health care's toughest choices — reporting you won't find anywhere else. If our work helps you stay informed, support it with a donation today. Hosted on Acast. See acast.com/privacy for more information.

About this episode:   At the turn of the 20th century, waterborne diseases like typhoid and dysentery posed a significant threat to public health, accounting for a large part of infant mortality and overall morbidity. Enter Abel Wolman, an early graduate of Johns Hopkins' engineering program and a professor at the university's school of public health. In this episode: the story of the Baltimore-born pioneer of water sanitization and how his work in water chlorination and infrastructure set the stage for better health across the globe.  Note: This episode was produced in collaboration with the Johns Hopkins University sesquicentennial campaign.  Guest:  Graham Mooney, PhD, is an associate professor of history of medicine and epidemiology at the Johns Hopkins School of Medicine.  Host:  Ari Goldstein, MD, is a family medicine physician and a recent alum of the Johns Hopkins Bloomberg School of Public Health General Preventive Medicine Residency program. This year, Dr. Goldstein served a one-month rotation with Public Health On Call.  Show links and related content:  Heroes of Public Health: Abel Wolman—Johns Hopkins Bloomberg School of Public Health  Friend of the Thirsty—New York Times

This episode's Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow' Sustainability Campaign, and how you can get involved: CLICK HEREEpisode Overview: American healthcare is at a crossroads, and the decisions we make now will define the health of generations to come.Dr. Marschall Runge has spent more than four decades at the center of that challenge, serving as former CEO of Michigan Medicine, Dean of the University of Michigan Medical School, and EVP for Medical Affairs.A practicing cardiologist trained at Johns Hopkins and Massachusetts General Hospital, Dr. Runge brings both the scientist's rigor and the leader's vision to one of the most urgent conversations of our time.In his Amazon and USA Today bestselling book, "The Great Healthcare Disruption," he lays out a bold prescription for reimagining American medicine through AI, innovation, and courageous systemic change.Join us to discover what it truly takes to transform healthcare from the inside out. Let's go!Episode Highlights:Dr. Runge never planned to be a CEO, initially dismissing healthcare leaders before serendipity shaped his path.His personal hospital-at-home experience after hip surgery confirmed that recovery is faster, cheaper, and better at home.Ambient AI, which auto-generates clinical notes, is the one decision at Michigan Medicine that faced almost no dissent.America's top-tier quaternary care leads the world; the real crisis is access, not quality.AI can address the clinician shortage in a year or two, something traditional training pipelines need decades to solve.About our Guest:Marschall S. Runge, M.D., Ph.D., was born in Austin, Texas, and graduated from Vanderbilt University with a BA in General Biology and a PhD in Molecular Biology. He received his medical degree from the Johns Hopkins School of Medicine and trained in internal medicine at Johns Hopkins Hospital. He was a cardiology fellow and junior faculty member at Massachusetts General Hospital. Dr. Runge's next position was at Emory University, where he directed the Cardiology Fellowship Training Program. He then moved to the University of Texas Medical Branch in Galveston, where he was Chief of Cardiology and Director of the Sealy Center for Molecular Cardiology. He joined the University of North Carolina (UNC) from 2000 – 2014, where he served as Charles Addison and Elizabeth Ann Sanders Distinguished Professor of Medicine, Chair of the Department of Medicine, President of UNC Physicians and Vice Dean for Clinical Affairs.Dr. Runge is the former CEO of Michigan Medicine and Dean of the University of Michigan Medical School, and a practicing cardiologist. Dr. Runge is board-certified in internal medicine and cardiovascular diseases and has spoken and published widely on topics in clinical cardiology and vascular medicine.At the University of Michigan, Dr. Runge began serving as the executive vice president for medical affairs in March 2015 and, in January 2016, he was also appointed as the dean of the Medical School. He is the first person to serve in this combined position created by the Regents for the purpose of strengthening the integration between the Medical School and health care delivery in our hospitals and health centers.During his tenure in these leadership roles, Dr. Runge has implemented transformative change and positioned Michigan Medicine and the Medical School for continued success. Notable achievements during this period include: a significant expansion of Michigan Medicine's clinical network in the state, through integration of two health systems, the former Metro Health in Grand Rapids and Sparrow Health System in Lansing, multiple joint ventures with Trinity Health, launch of the Precision Health Initiative, a major research collaboration with several other U-M schools and colleges; oversight of the conclusion of the Victors for Michigan campaign which raised $1.5 billion dollars for institutional strategic priorities; and the development and implementation of Michigan Medicine's first strategic plan for diversity, equity and inclusion in support of the broader university-wide DEI initiative.Under Dr. Runge's leadership, the University of Michigan Health's adult hospitals were ranked best in Michigan in 2023-2024 in U.S. News & World Report “Best Hospitals” rankings, the 31st consecutive year that U-M Health has been nationally recognized for strong across-the-board performance. In Newsweek's 2024 ranking of America's Best Hospitals, U-M Health ranked #1 in the state and #3 in the country.Current and new initiatives under Dr. Runge's leadership include construction of the The D. Dan and Betty Kahn Health Care Pavilion, a 12-story and 264 private room inpatient hospital; working to reduce faculty and staff burnout; executive rounding to help promote employee engagement and retention; establishment of the Heart Brain Institute and Global Health; oversight and development of the Anti-Racism Oversight Committee to help achieve an anti-racist culture; improved access and patient experience through the M2C2 Capacity Center; and the establishment of the Care at Home initiative which focuses on providing safe, hospital-level care to patients in their own home.Dr. Runge has been a physician-scientist for his entire career, combining basic and translational research with the care of patients with cardiovascular diseases and education. He is the author of over 200 publications in the field and holds five patents for novel approaches in health care.Links Supporting This Episode: Dr. Marschall Runge Website: CLICK HEREDr. Marschall Runge LinkedIn page: CLICK HEREThe Great Healthcare Disruption book link: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form: CLICK HERE

Over the past decade or so, the United States has pursued an approach to global trade that seems to rest on the idea that globalization has not worked, that we have lost too much, and that the world is taking advantage of us. From Hilary Clinton campaigning against the Trans-Pacific Partnership (a free trade agreement she worked to craft) to the current tariff frenzy, politicians on both sides of the aisle have blamed trade for a whole host of problems here in the U.S. However, as the U.S. moved in a more protectionist direction over the past three administrations, the rest of the world continues to craft trade deals that go around the United States. In this month's episode, we take a look at the history of international trade and unpack how things have shifted from the protectionism of the 1930s, to the opening of trade in the Post World War II era, and into today. It remains fascinating that Americans, for the most part, are supportive of free and open trade with other countries, that majorities do not like the tariffs, and many would be disappointed to see their favorite products disappear from store shelves, that both Parties are implementing policies that fly in the face of public opinion.Join the global conversation to take a deeper dive into the world of trade, its challenges, and what it looks like when the United States decides to sit on the sidelines. William Reinsch is a senior adviser and Scholl Chair emeritus with the Economics Program and Scholl Chair in International Business at the Center for Strategic and International Studies (CSIS). Previously, he was a senior advisor at the law firm of Kelley, Drye & Warren and served for 15 years as president of the National Foreign Trade Council, which represents multinational companies on international trade and tax policy issues. From 2001 to 2016, he concurrently served as a member of the U.S.-China Economic and Security Review Commission. He is also an adjunct assistant professor at the University of Maryland School of Public Policy, teaching a course in trade policy and politics. Reinsch also served as the under secretary of commerce for export administration during the Clinton administration. Prior to that, he spent 20 years on Capitol Hill, most of them as senior legislative assistant to the late senator John Heinz (R-PA) and subsequently to Senator John D. Rockefeller IV (D-WV). He holds a BA and an MA in international relations from the Johns Hopkins University and the Johns Hopkins School of Advanced International Studies respectively.

Send us Fan MailHeart disease remains the leading cause of death worldwide, and one of its most important modifiable risk factors is elevated LDL cholesterol - the so-called "bad cholesterol." While statins have transformed cardiovascular care for decades, and newer therapies like injectable PCSK9 inhibitors have provided additional options, millions of patients still struggle to achieve recommended LDL cholesterol targets.In fact, despite the availability of effective therapies, roughly seventy percent of patients receiving cholesterol-lowering treatment still fail to reach guideline-recommended LDL cholesterol levels. The reasons are complex - from biology and treatment intensity to adherence and convenience - but the result is the same: preventable heart attacks, strokes, and cardiovascular deaths continue to occur.Now, a new chapter is beginning. Following years of clinical development, the FDA has approved LIPFENDRA™ (enlicitide), the first oral PCSK9 inhibitor, introducing an entirely new approach to LDL cholesterol reduction ( https://www.lipfendra.com/ ).Joining us today is someone uniquely qualified to help us understand what this approval means for physicians and patients.Dr. Norman Lepor, MD is Founder and Director of the National Heart Institute ( https://nationalheartinstitute.org/about/meet-our-team ), Clinical Professor of Medicine at the David Geffen School of Medicine at UCLA, and an Attending Cardiologist at the Smidt Heart Institute at Cedars-Sinai ( https://www.cedars-sinai.org/provider/norman-lepor-106852.html ). A graduate of Johns Hopkins School of Medicine, Dr. Lepor has spent more than four decades advancing cardiovascular medicine through patient care, education, and clinical research. He has served as principal investigator on more than sixty clinical trials, authored dozens of influential scientific publications, and has been recognized by U.S. News & World Report as one of America's leading cardiologists. Throughout his career he has also been a champion for women's cardiovascular health and improving access to cutting-edge care for underserved populations.Today we'll discuss why LDL cholesterol remains such a difficult public health challenge, what we've learned over the past three decades of lipid management, how oral PCSK9 inhibition works, and what this newly approved therapy may mean for the future of preventing heart attacks and strokes.#HeartHealth #Cholesterol #LDL #Cardiology #HeartDisease #Prevention #PreventiveMedicine #LIPFENDRA #Enlicitide #PCSK9 #PrecisionMedicine #Longevity #CardiovascularHealth #MedicalInnovation #Biotech #FutureOfMedicine #HealthyAging #SciencePodcast #ProgressPotentialPossibilities #PPPPodcastSupport the show

Matthew Davis is the author of “When Things Get Dark: A Mongolian Winter's Tale.”    He has been an Eric and Wendy Schmidt Fellow at New America, a Fellow at the Black Mountain Institute at UNLV, and a Fulbright Fellow to Syria and Jordan. He holds an MFA in nonfiction writing from the University of Iowa and an MA in International Relations from the Johns Hopkins School of Advanced International Studies.  His recent book is “A Biography of a Mountain: The Making and Meaning of Mount Rushmore.” From the grandeur of Mount Rushmore, located in the Black Hills of South Dakota, to the spiritual serenity of the Leshan Giant Buddha in China, Petra in Jordan, Ellora Caves in India. These carvings connect us to our past and inspire us to appreciate the beauty and complexity of our shared heritage, as well as ensure their stories and significance endure for future generations.

Follow along on social media @therapybookspodcast *Information on this podcast is for informational and educational purposes only. Book (affiliate link) Psychotherapist and host Jessica Fowler interviews sports and health psychologist Dr. Carly Hunt about her book, Train Your Brain to Beat Chronic Pain: How to Harness the Power of the Mind-Body Connection.  In addition to sharing about her history of childhood medical trauma and intermittent pain, Dr. Hunt explores many aspects of chronic pain including how trauma can contribute to nervous system sensitization.  Dr. Hunt emphasizes building a multidisciplinary care team, activity pacing with time-contingent rest, and mindfulness to reduce pain-related worry. Show Highlights How Chronic Pain Works Grief/Hope Stressors How to Start with Understanding/Accepting Chronic Pain Mindfulness Skills Pain Reprocessing Therapy Five Percent Wins Integrative Care Plan About the author: Dr. Carly Hunt is a sport & health psychologist, author, consultant, and former D1 golfer. Her holistic approach blends sport, health, and positive psychology to help people build inner resources that support excellence and mind-body health. She completed her BA in Psychology from Georgetown University, MA in Kinesiology and PhD in Counseling Psychology from the University of Maryland, and postdoctoral fellowship at the Johns Hopkins School of Medicine. Find her on the web at www.presentmindconsulting.com and www.thinkbettergolf.com.

The period immediately after hospital discharge is a critical yet often overlooked phase in stroke recovery, marked by both heightened vulnerability and opportunities for rapid brain repair. This episode explores the concept of transitional stroke care, emphasizing early specialist follow up, coordinated multidisciplinary support, and targeted interventions to improve outcomes and reduce complications. In this episode, Katie Grouse, MD, FAAN, speaks with Mona N. Bahouth, MD, PhD, FAAN, author of the article "Transitional Stroke Care and the Road to Recovery" in the Continuum® June 2026 Cerebrovascular Disease issue. Dr. Grouse is a Continuum® Audio interviewer and a clinical assistant professor at the University of California, San Francisco in San Francisco, California. Dr. Bahouth is the medical director of the Brain Rescue Unit and an associate professor of neurology at Johns Hopkins School of Medicine in Baltimore, Maryland. Additional Resources Read the article: Transitional Stroke Care and the Road to Recovery Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Guest: @MonaBahouth Full episode transcript available here Dr Grouse: A lot of attention has been paid to what happens within hours to days of a stroke, but are we missing an equally crucial time in our patient's recovery after their discharge? Today, I have the opportunity to interview Dr. Mona Bahouth about the latest issue of Continuum on cerebrovascular disease.  Dr Jones: This is Dr. Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast.  Dr Grouse: This is Dr. Katie Grouse. Today, I'm interviewing Dr. Mona Bahouth about her article on transitional stroke care and the road to recovery. This article appears in the June 2026 Continuum issue on cerebrovascular disease. Welcome to the podcast, and please introduce yourself to our audience.  Dr Bahouth: Thank you for having me. I'm Mona Bahouth. I'm a stroke neurologist in Baltimore, Maryland, and I'm the medical director of our brain rescue unit at the Johns Hopkins Hospital. Great to be with you.  Dr Grouse: Thank you so much. This was a very interesting article. I have to confess going into it, I really didn't know a lot about transitional stroke care and the growing sort of recognition of its importance for stroke recovery and improved outcomes. Can you tell me what the key message from this article is that you really hope that readers will take away after reading it and hopefully integrate into their own patient practices?  Dr Bahouth: Yeah. I would say if there's one overarching message, it is that stroke care has come so far over the last couple of decades. We do so much wonderful life-saving work in the first couple of hours and days after stroke, but we haven't really paid as much attention to what happens once a patient leaves the hospital with this devastating acute disease. And I would just like to say that this article allows us to shine a light on providing a little bit more of a system of care, a more structured system of care that could benefit the patient for the long term, then that will benefit a large population of patients who otherwise may have complications that could cause disability longer in life.  Dr Grouse: Now, Mona, could you tell us in a nutshell, what is transitional stroke care, and why are we needing to focus more of our attention on this to improve patient recovery?  Dr Bahouth: Yeah. Over the last few years, we've really done a wonderful job of reducing the time that a patient spends in a hospital after stroke care. But in parallel, we have not really changed anything about what we do in the outpatient setting. So, a patient tells us that they come to the hospital with this acute and very scary and disabling disease. They feel that they're the center of the universe at our stroke centers, where we're hustling around them in groups and in interprofessional teams. But then on the day of discharge, they feel that they leave the hospital, and in some of our focus groups, that they kind of go home to a, a dark bedroom where they have to process all of this sort of on their own. It's quite a transition for both patients and their care partners. And here we've been very systematic about how we structure our care in the hospital for stroke patients, but once they leave the hospital, it's been a sort of free-for-all, or the Wild West, as some of my colleagues say. So transitional stroke care is really a way to extend the care that we deliver in the stroke unit to the patient's home or to their next phase of care. We know that stroke patients have 11 handoffs from beginning to end, in average, that they experience through the course of their acute stroke. And so, what we're really trying to do is extend the, the stroke unit to the patient's home or to their next phase of care so that they feel a bit more extension of that specialty care that they were receiving in the hospital. So, it's really a structure, a system.  Dr Grouse: Now, it seems that when we're thinking about the transitional care period, that it really hinges on this idea of sort of the sensitive period of stroke recovery. What is that, and why is that so important, and why do we really need to focus on that specific time?  Dr Bahouth: There are really two reasons that this is a critical period for patients. One is that we know from work in animal models as well as other sort of human early studies that the brain really has its optimal period of efficient brain repair in the first few weeks after stroke, meaning that it's recovering after this injury and figuring out how to reroute some really important brain functions. I would say it's also a critical period because the time period after stroke is a period that all the comorbid conditions that sort of conspired to cause a stroke are sometimes destabilized. And we know that sort of just putting people back on standard regimens for their hypertension, their diabetes, their heart failure doesn't always equate to sort of long-term improved outcomes at a time that the brain itself is going through changes. So, for example, we know that blood flow is critical to the brain. That's what all the hustle is about in the hyperacute period. And for the next couple of weeks after a stroke, autoregulation remains disrupted, so typical treatments of hypertension could have negative consequences for a subpopulation of patients. This management of hypertension needs to continue for a couple of days and weeks after stroke, and therefore, if a patient is discharged from the hospital, really requires a bit more specialty input. We also know that as the brain is trying to repair during the sensitive period, this high period of efficiency, we really want to inject high-intensity, high-quality activities that really improve their recovery. But in our current system in the United States, our transition to the period of rehabilitation is really quite clunky and disrupted and doesn't often happen in a seamless way. So, a true transitional stroke care program really attempts to manage the stroke itself. The comorbid conditions that conspire to cause the stroke, and the expedition of, of rehabilitation that could really jumpstart the recovery period in a more meaningful way.  Dr Grouse: Now, you mentioned hypertension as being sort of a critical factor that can affect the patients during this transitional period or this sensitive period. What are some other factors that can really play a huge part in their long-term outcomes in this really sensitive time?  Dr Bahouth: In our transitional stroke program, in our interprofessional group, we often talk about all of the changes that a patient is required to make at the time of stroke. Typically, they stay in the hospital several days. The patient and their care partner will receive a bolus of instructions about what their new healthier life should look like, and then they're sort of sent off to sort of self-manage without really accepting that that wasn't the perfect time to teach these things. So really, it's all about sort of lifestyle improvement. How do we get into a system of medication adherence when medications are a central portion of a patient's care? It is about managing the cognitive changes that happen after stroke, whether we acknowledge them in the hospital as a main deficit or something that people realize once they get back into the groove of their usual life, and the emotional consequences of stroke for both the patient and their care partner, who are both adjusting to this very scary moment that resulted in a brain injury. So, I think that the things that are focused on are both medical in terms of, you know, what are we doing with the diabetes? Is our glucose at a target range? Have we started wearing our sleep apnea paraphernalia? Are we managing our smoking cessation as much as we should? How have we done with our low-fat diet? Are we taking our medications as prescribed, or was there some cognitive blip that caused a mistake? But also sort of the emotional support that sometimes paralyze patients into sort of saying they cannot handle this transition into a new healthier way of brain recovery.  Dr Grouse: Yes, and it sounds like when patients sort of hit that wall, they almost just give up, right? There's just so many things they have to manage. They're emotionally trying to cope, and then they may eventually get to their neurologist at some point for a follow-up, and not much has happened.  Dr Bahouth: That's a really well-put statement. Like I mentioned earlier, we had several focus groups to say, "How's our stroke center doing? How is our comprehensive stroke center doing?" And we realized that we were very comprehensive while the patient was with us, but then the experience of the patient going home was really opposite of receiving comprehensive care. You know, the patient in the hospital said they felt well-supported, surrounded, quite busy all the time, but then they did go home, and this sort of set in that they've had a stroke. And many patients told us, "I just laid in bed because I couldn't quite kind of get through the thought that this has happened to me." And so, in our prior state of our comprehensive stroke system where patients weren't seen for a couple of months after their discharge, patients would tell me, "Well, I'm fine now.  But those first couple of months, I sure wasn't. You know, I was laying in bed. I was crying. I wasn't taking my medicines. I had a lot of despair and fear." Care partners would say, "I wasn't sleeping myself. I was watching to see if another stroke was gonna happen every minute." So, there are a lot of elements that are going on in those first two weeks that really require a specialist to say, "This is normal. This requires more attention," and to really help people get through a lot of the changes that come with stroke and brain injury.  Dr Grouse: Now, your article gave a really great, I think, example, where you had a juxtaposition of a hypothetical patient with a stroke and two very different post-discharge courses, one where they really kind of fell into that vacuum, that post-discharge vacuum, where they didn't get support and had some very disappointing outcomes versus a patient who did have a transitional care program with a lot of support post-discharge, and a lot of obstacles were overcome and problems solved such that the patient could do a lot better. And I encourage our listeners to take a look at it. If you could design and run it, how would your ideal transitional post-stroke program be structured? Like, how would you design it so that it would optimally support these patients?  Dr Bahouth: Yeah, you know, we, um, tangle with this every day in our current transitional stroke program that we call the JSTEP program. We've had several chapters of what we think is ideal for a patient, and thank you for sort of acknowledging that, like, the way those cases were written were really to underscore that we can have a lot of influence for patients. And while they were sort of hypothetical juxtapositions of one another, these are things we literally see every single day for our stroke patients. And people say, "Oh, if only we had done this, we would've caught that, and we would've prevented such-and-so." Some of the indicators of success have been we've really reduced our readmission rates to the hospital. We have decreased our length of stay because the confidence people feel to go home because they're well supported. So there have been indicators of success. But if I could take our program even next level, I would probably include a few other things. So currently, some of the strengths of the program are that a stroke specialist sees a patient within days of their discharge from the hospital, a time where some of those questions are sort of raising for the patient. Maybe a complication is starting to pop up that we can address before it, uh, gets out of hand and requires a readmission. We can tackle some of the fears that patients are having to say, "I wonder if this is normal or not. I better just go to the hospital." So, some of that early touch point by a true stroke specialist is really critical. And that visit only happens because the seed is planted in the hospital, so there really has to be some initiation of the program at the time the patient is in the hospital to say, "This is what you can expect when you leave here. You have someone who's walking this with you. They're a stroke specialist. They're gonna know how to help you navigate." The second part of our program that is a success is our rapid connection to specialties. So, we know that stroke patients are gonna need connection to rehabilitation specialists, physiatrists, the therapists. We know they're gonna need connection to cardiology when atrial fibrillation or heart failure or something is really at an extreme.We know endocrinology might be a part of the patient's story going forward. And so, I think the second success of our program is really alliance with key stakeholders in a stroke patient's life and quick access to having the patient be connected to what it is they need in the moment that we realize that there is a situation at home. The third thing that I think has been really a success of our program is this interprofessional education that we schedule patients for at the time of their discharge, just as any other important healthcare visit. During this interprofessional education session, the patients get to meet dietician, pharmacist, nurse, therapist, where key discussions about healthy behaviors, avoidance of complications after stroke really happen in a group session where there can be a lot of interaction. You know, currently our education happens in a time where the brain is injured, the patient is not sleeping well in the hospital. We have a lot of stress and fear. It's not the perfect time for anyone to receive such important education. So, I think the third really most important thing has been this formalized interprofessional education to really bolster the education that started at the hospital. If I were to really take our program next level, and every day we're considering it, I really think we haven't done a couple of key things. One is we have not really found a way for the care partner to be supported, that the care partner is usually the brave one sitting there with a tight lip and nodding and very, you know, concerned about what's happening and taking close notes. But we really haven't done well to just manage the care partner's needs sort of independently of the patient themselves, sort of help them with the experience of going through this. I think that could benefit both the care partner and the patient by sort of bolstering their sort of emotional consequences of this. And they are really our key partner in the patient's success in the outpatient setting, getting the patient motivated, helping them get to appointments, helping them to adhere with medications. So, I think if we can focus a bit more on the care partner, that might really bolster the long-term effect for patients. And I think finally, behavior change is very complex. Sometimes we're taking a group of patients who may have never exercised and said, "You know, we really... You need to walk several minutes a day. You need to increase your aerobic capacity. We need you to stop smoking." And these are not behavior changes that can just happen with sort of a one-time visit. So, I think we really need to incorporate a lot more of exercise therapy and concepts of people who can sort of coach along the continuum for some of these behavior changes so that we can really promote wellness and a return to health. And I think one final thing that could be additive from a transitional stroke program is really a better way to truly measure recovery for stroke patients, some of those in between the line measures that we're not really getting by a three-month modified Rankin score. I think a transitional stroke care model would really allow us to both insert research and potential other therapies along this time period, but also measure the success of those in a more granular way.  Dr Grouse: Thank you so much for that, and also it was really helpful to get a good overview of, like, what the transitional care program really means, right? Like, what is the structure? What is happening with the patient? So, I think all of that's really helpful. But I can't help but think, listening to all of that, that sounds like while certainly in an ideal state, and I don't think anyone can argue with how helpful that sounds, is it always something that's practical? Can we implement things like this, especially where access is limited, resources are dwindling as far as what patients can get and what evaluations patients can get? Do you think that this is something that can actually be implemented in programs throughout the country? And what are strategies we can consider to try to improve getting some of these resources for our patients?  Dr Bahouth: I think this is such a critical topic. I think that we have, in the medical system, tried to force our healthcare practices into old models of care instead of sort of adopting new ones. And so, I think that, you know, while everyone says, "Wow, that sounds like a very resource-rich program," I would have to stop and push back and say, well, a very resource-rich situation is when a stroke patient, sometimes fifteen to twenty percent of the time, are readmitted to the hospital at a time where hospital beds are at a premium. Maybe we need to turn those dollars of savings of sort of these readmissions and extra length of stay into dollars that we put into sort of this transitional period where we help promote success. So, I think it really becomes more of a value proposition when you talk about it. But that said, of course, we have to make sure that we're a high-value, high-productivity system. So, our current transitional care program uses a telemedicine structure. We know that stroke patients cannot drive in most states after their stroke. We know that their care partners are trying to return to work and normalize. It is very difficult for patients with paralysis, cognitive changes to come back and forth to multiple appointments. In the past, we have tried to make this transitional care program an in-hospital program. I think using the technologies that we have available for telemedicine are critical, especially for this population who have barriers to getting to their appointments. So, I think with a very low resource investment, a transitional care program can be created once you really develop the skills of the, the stroke team to really reach beyond the hospital with the tools that we already have in the hospital and just extend that to the next chapter. It is an investment, most certainly, but I think it's one well worth the investment for the patient's success, their quality of life, as well as some of the value metrics that we judge our hospitals by.  Dr Grouse: Are some of the transitional care codes that CMS has put out in recent years helpful to get some reimbursement for these types of visits?  Dr Bahouth: Absolutely. So, I think that's been a really wonderful policy change that has happened, recognizing the importance of these transitional care models. There are billing codes that allow you to have higher billing than a usual neurology appointment when a patient is within a certain window, meeting certain criteria for their eligibility for such a visit.There are codes that have now been developed and are being more and more utilized to have visits with care partners and realize that the care partner is an important member of the equation of this patient's success. So, there are definitely codes that can be used. I think we're very good in healthcare of delivering a lot of free care, but that's not the nature of the beast these days. We have to really be very aware of our dollars and cents, and so utilizing some of these important codes that I hope only continue to expand to recognize the importance of the transitional period for patients.  Dr Grouse: Now, Mona, I wanted to ask, was there anything that you wish you could have included in this article that didn't make it in?  Dr Bahouth: You know, obviously, um, word limitations are always challenging. I think that the article, I think, does a good job going sort of from beginning to end. I think a deeper section, certainly we have commented on the sort of sociodemographic challenges of a program like this that also relies on a technology like telemedicine in many cases. But there are so many nuances to that conversation that I think that section could have definitely gone on for a much longer period of time to talk about some of the strategies, the strategic ways that we work hard to make sure that these type of transitional care programs are accessible to all, especially the vulnerable who may have challenges with accessing technology. But I will say it is possible. You know, we are in a urban city. We see a lot of patients with various insurance status and access to technologies, and we've had a very high show rate in our post-hospital transitional program, so it can be done with a thought and, uh, care to those vulnerable populations who may need more attention across the transition.  Dr Grouse: Well, I really appreciate all the work you've done in this area, and it sounds like it's an area that will continue to grow as we learn more and hopefully improve. And I really appreciate you taking the time out of your day to talk with us about your article.  Dr Bahouth: Well, thank you for having me, and it's a topic that's near and dear to us, so thanks again for highlighting its importance.  Dr Grouse: Again, today I've been interviewing Dr. Mona Bahouth about her article on transitional stroke care and the road to recovery. This article appears in the June 2026 Continuum issue on cerebrovascular disease. Be sure to check out Continuum Audio episodes from this and other issues, and thank you to our listeners for joining today.  Dr Monteith: This is Dr. Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

The Catholic Church has traditionally been sympathetic to the aspirations of West Papuans.But, over the past year, rebels in the Indonesian province of West Papua have attacked several Catholic institutions. The worst was early July, when they killed an American pilot, whose plane was carrying aid for Catholic charities. What's behind these attacks by anti-Indonesian rebels? GUEST:Ahmad Syarif is a researcher at Johns Hopkins School of Advanced International Studies in Washington. He spent nearly a decade at the Jakarta office of Bower Group Asia. He recently documented the growing violence in a report for The Lowy Interpreter.

The conflict involving Iran has entered another period of uncertainty, with diplomatic efforts faltering and regional tensions rising once again. In this episode of Current Account, Clay is joined by Hal Brands, professor at the Johns Hopkins School of Advanced International Studies and columnist for Bloomberg Opinion, to assess the latest developments and what they could mean for the Middle East and beyond. They discuss the collapse of recent diplomatic agreements, the strategic objectives of the key parties involved, and how Gulf states are balancing security concerns with efforts to prevent further escalation. The conversation also explores the implications for NATO, global energy markets, and the range of scenarios policymakers and investors should be watching in the weeks ahead. This IIF Podcast was hosted by Clay Lowery, Executive Vice President, Research and Policy, with production and research contributions from Christian Klein, Digital Graphics and Production Associate and Miranda Silverman, Senior Program Assistant.

In this episode, host Pierce Salguero sits down with Linda C. Ceriello, a scholar of mysticism and popular culture from Kennesaw State University in Georgia. Linda is one of the foremost scholars of metamodernism, with particular focus on contemporary spirituality and mystical experiences. She talks with us about what this concept of metamodernism means, and how it can open up new kinds of more capacious thinking. I'm sure you will agree that a lot of what we've been doing on the Black Beryl podcast over the past 4 years — juxtaposing different perspectives, exposing our full selves, exploring the dark sides of spirituality, leaning into sincerity, etc. — has all embodied a metamodern sensibility. Anyway, I think she's the perfect guest to talk with as we launch season 4, and I hope you'll enjoy the show. If you want to hear scholars and practitioners engaging in multidisciplinary conversations about Asian healing and mystical traditions, then subscribe to Black Beryl wherever you get your podcasts. Also check out our members area on Substack (blackberyl.substack.com), as each episode our guests share downloadable PDFs of articles, book chapters, and other materials for you. One last thing: we are planning an “Ask Me Anything” episode coming up soon, so reach out via Substack or my website here, and let me know your questions. Ok, on with the show! Resources mentioned in this episode: “What is Metamodern?” website “What is Metamodern? Conversations” on YouTube Bloomsbury Press series: Studies in Metamodernism, Theory and Criticism Across the Disciplines Vermeulen and van den Akker, “Notes on Metamodernism” (2010) Kersten, Polo, Wilbers, Glocal Metamodernisms: European Fiction After Postmodernism (2026) Disambiguation video Recorded lecture: “An Overview of the Academic Research on Metamodernism” (2023) Recorded panel: “A Bodhisattva Move: Popular Mysticism's Influence on the Metamodern Turn?” (2021) Subscribe on blackberyl.substack.com to unlock our members-only benefits, including these PDFs of Linda's work: Metamodern Mysticisms (2018) “Toward a metamodern reading of Spiritual but Not Religious mysticisms” (2018) “The Metamodern Bend: Theorizations for Religious Studies” (2022) Black Beryl's host Pierce Salguero is a transdisciplinary scholar of health humanities who is fascinated by historical and contemporary intersections between Buddhism, medicine, and crosscultural exchange. He has a Ph.D. in History of Medicine from the Johns Hopkins School of Medicine and teaches Asian history, medicine, and religion at Penn State University's Abington College, located near Philadelphia. See www.piercesalguero.com Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

In this episode, host Pierce Salguero sits down with Linda C. Ceriello, a scholar of mysticism and popular culture from Kennesaw State University in Georgia. Linda is one of the foremost scholars of metamodernism, with particular focus on contemporary spirituality and mystical experiences. She talks with us about what this concept of metamodernism means, and how it can open up new kinds of more capacious thinking. I'm sure you will agree that a lot of what we've been doing on the Black Beryl podcast over the past 4 years — juxtaposing different perspectives, exposing our full selves, exploring the dark sides of spirituality, leaning into sincerity, etc. — has all embodied a metamodern sensibility. Anyway, I think she's the perfect guest to talk with as we launch season 4, and I hope you'll enjoy the show. If you want to hear scholars and practitioners engaging in multidisciplinary conversations about Asian healing and mystical traditions, then subscribe to Black Beryl wherever you get your podcasts. Also check out our members area on Substack (blackberyl.substack.com), as each episode our guests share downloadable PDFs of articles, book chapters, and other materials for you. One last thing: we are planning an “Ask Me Anything” episode coming up soon, so reach out via Substack or my website here, and let me know your questions. Ok, on with the show! Resources mentioned in this episode: “What is Metamodern?” website “What is Metamodern? Conversations” on YouTube Bloomsbury Press series: Studies in Metamodernism, Theory and Criticism Across the Disciplines Vermeulen and van den Akker, “Notes on Metamodernism” (2010) Kersten, Polo, Wilbers, Glocal Metamodernisms: European Fiction After Postmodernism (2026) Disambiguation video Recorded lecture: “An Overview of the Academic Research on Metamodernism” (2023) Recorded panel: “A Bodhisattva Move: Popular Mysticism's Influence on the Metamodern Turn?” (2021) Subscribe on blackberyl.substack.com to unlock our members-only benefits, including these PDFs of Linda's work: Metamodern Mysticisms (2018) “Toward a metamodern reading of Spiritual but Not Religious mysticisms” (2018) “The Metamodern Bend: Theorizations for Religious Studies” (2022) Black Beryl's host Pierce Salguero is a transdisciplinary scholar of health humanities who is fascinated by historical and contemporary intersections between Buddhism, medicine, and crosscultural exchange. He has a Ph.D. in History of Medicine from the Johns Hopkins School of Medicine and teaches Asian history, medicine, and religion at Penn State University's Abington College, located near Philadelphia. See www.piercesalguero.com Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/religion

In this episode, host Pierce Salguero sits down with Linda C. Ceriello, a scholar of mysticism and popular culture from Kennesaw State University in Georgia. Linda is one of the foremost scholars of metamodernism, with particular focus on contemporary spirituality and mystical experiences. She talks with us about what this concept of metamodernism means, and how it can open up new kinds of more capacious thinking. I'm sure you will agree that a lot of what we've been doing on the Black Beryl podcast over the past 4 years — juxtaposing different perspectives, exposing our full selves, exploring the dark sides of spirituality, leaning into sincerity, etc. — has all embodied a metamodern sensibility. Anyway, I think she's the perfect guest to talk with as we launch season 4, and I hope you'll enjoy the show. If you want to hear scholars and practitioners engaging in multidisciplinary conversations about Asian healing and mystical traditions, then subscribe to Black Beryl wherever you get your podcasts. Also check out our members area on Substack (blackberyl.substack.com), as each episode our guests share downloadable PDFs of articles, book chapters, and other materials for you. One last thing: we are planning an “Ask Me Anything” episode coming up soon, so reach out via Substack or my website here, and let me know your questions. Ok, on with the show! Resources mentioned in this episode: “What is Metamodern?” website “What is Metamodern? Conversations” on YouTube Bloomsbury Press series: Studies in Metamodernism, Theory and Criticism Across the Disciplines Vermeulen and van den Akker, “Notes on Metamodernism” (2010) Kersten, Polo, Wilbers, Glocal Metamodernisms: European Fiction After Postmodernism (2026) Disambiguation video Recorded lecture: “An Overview of the Academic Research on Metamodernism” (2023) Recorded panel: “A Bodhisattva Move: Popular Mysticism's Influence on the Metamodern Turn?” (2021) Subscribe on blackberyl.substack.com to unlock our members-only benefits, including these PDFs of Linda's work: Metamodern Mysticisms (2018) “Toward a metamodern reading of Spiritual but Not Religious mysticisms” (2018) “The Metamodern Bend: Theorizations for Religious Studies” (2022) Black Beryl's host Pierce Salguero is a transdisciplinary scholar of health humanities who is fascinated by historical and contemporary intersections between Buddhism, medicine, and crosscultural exchange. He has a Ph.D. in History of Medicine from the Johns Hopkins School of Medicine and teaches Asian history, medicine, and religion at Penn State University's Abington College, located near Philadelphia. See www.piercesalguero.com Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/spiritual-practice-and-mindfulness

In this episode, host Pierce Salguero sits down with Linda C. Ceriello, a scholar of mysticism and popular culture from Kennesaw State University in Georgia. Linda is one of the foremost scholars of metamodernism, with particular focus on contemporary spirituality and mystical experiences. She talks with us about what this concept of metamodernism means, and how it can open up new kinds of more capacious thinking. I'm sure you will agree that a lot of what we've been doing on the Black Beryl podcast over the past 4 years — juxtaposing different perspectives, exposing our full selves, exploring the dark sides of spirituality, leaning into sincerity, etc. — has all embodied a metamodern sensibility. Anyway, I think she's the perfect guest to talk with as we launch season 4, and I hope you'll enjoy the show. If you want to hear scholars and practitioners engaging in multidisciplinary conversations about Asian healing and mystical traditions, then subscribe to Black Beryl wherever you get your podcasts. Also check out our members area on Substack (blackberyl.substack.com), as each episode our guests share downloadable PDFs of articles, book chapters, and other materials for you. One last thing: we are planning an “Ask Me Anything” episode coming up soon, so reach out via Substack or my website here, and let me know your questions. Ok, on with the show! Resources mentioned in this episode: “What is Metamodern?” website “What is Metamodern? Conversations” on YouTube Bloomsbury Press series: Studies in Metamodernism, Theory and Criticism Across the Disciplines Vermeulen and van den Akker, “Notes on Metamodernism” (2010) Kersten, Polo, Wilbers, Glocal Metamodernisms: European Fiction After Postmodernism (2026) Disambiguation video Recorded lecture: “An Overview of the Academic Research on Metamodernism” (2023) Recorded panel: “A Bodhisattva Move: Popular Mysticism's Influence on the Metamodern Turn?” (2021) Subscribe on blackberyl.substack.com to unlock our members-only benefits, including these PDFs of Linda's work: Metamodern Mysticisms (2018) “Toward a metamodern reading of Spiritual but Not Religious mysticisms” (2018) “The Metamodern Bend: Theorizations for Religious Studies” (2022) Black Beryl's host Pierce Salguero is a transdisciplinary scholar of health humanities who is fascinated by historical and contemporary intersections between Buddhism, medicine, and crosscultural exchange. He has a Ph.D. in History of Medicine from the Johns Hopkins School of Medicine and teaches Asian history, medicine, and religion at Penn State University's Abington College, located near Philadelphia. See www.piercesalguero.com Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/popular-culture

Ward Rinehart is an American who lives and works in the Jura Mountains of France. He co-manages Jura Editorial Services, a small business editing and writing English-language publications for international organizations in nearby Geneva, Switzerland, and for clients worldwide. Prior to moving to France, he worked in international health communication for 30 years at Johns Hopkins School of Public Health in Baltimore, MD. "Working as a reporter for a newspaper in Springfield, Massachusetts, I learned what was satisfying to me, was to learn something and then be able to use that to help other people understand issues they faced or the concerns they might want to get involved in, and issues that were going to affect their lives."

Dr. GG deFiebre of SRNA spoke with Dr. Michael Levy and Dr. Benjamin Greenberg about CAR-T therapy for aquaporin-4-positive NMOSD. They described why targeting B cells may reduce aquaporin-4 antibodies over time and could enable long-term remission or reduced need for ongoing drugs [01:37]. The physicians outlined an autologous Phase 1 study at Mass General and UT Southwestern [07:02]. They discussed eligibility rationale and how lessons from this NMOSD-focused trial could inform future neuroimmune disorder research [09:10]. You can find more information about the trial here:https://clinicaltrials.gov/study/NCT07573332?cond=NMOSD&intr=CAR-T&viewType=Card&rank=1Benjamin M. Greenberg, MD, MHS is a Professor and the Cain Denius Scholar in Mobility Disorders in the Department of Neurology [https://utswmed.org/why-utsw/departments/neurology/] at UT Southwestern Medical Center in Dallas, Texas. He currently serves as the Vice Chair of Translational Research and Strategic Initiatives for the Department of Neurology. He is also the interim Director of the Multiple Sclerosis Center [https://utswmed.org/locations/aston/multiple-sclerosis-and-neuroimmunology-clinic/] and the Director of the Neurosciences Clinical Research Center. In addition, he serves as Director of the Transverse Myelitis and Neuromyelitis Optica Program and the Pediatric Demyelinating Disease Program [https://www.childrens.com/specialties-services/specialty-centers-and-programs/neurology/demyelinating-disease-program] at Children's Medical Center.Dr. Greenberg earned his medical degree at Baylor College of Medicine before completing an internal medicine internship at Chicago's Rush Presbyterian-St. Luke's Medical Center. He performed his neurology residency at the Johns Hopkins School of Medicine. He also holds an M.H.S. in molecular microbiology and immunology from the Bloomberg School of Public Health, as well as a bachelor's degree in the history of medicine – both from Johns Hopkins. Prior to his recruitment to UT Southwestern in 2009, Dr. Greenberg was on the faculty of the Johns Hopkins Division of Neuroimmunology, serving as the Director of the Encephalitis Center and Co-Director of the nation's first dedicated Transverse Myelitis Center.Dr. Greenberg splits his clinical time between adult and pediatric patients at William P. Clements Jr. and Zale Lipshy University Hospitals, Parkland, and Children's Medical Center. His research focuses on better diagnosing, prognosticating, and treating demyelinating diseases and nervous system infections. He also coordinates clinical trials to evaluate new treatments to prevent neurologic damage and restore function to affected patients. Michael Levy, MD, PhD is a recognized neurologist with over 15 years of clinical and research expertise in rare neuroimmunological disorders. He established the Neuroimmunology Clinic and Research Laboratory at Massachusetts General Hospital and is the Research Director in the Division of Neuroimmunology and Neuroinfectious Disease. Previously, Dr. Levy was on the faculty at Johns Hopkins University and was the founding Director of their Neuromyelitis Optica Clinic. Clinically, Dr. Levy cares for patients with MOG antibody disease (MOGAD), neuromyelitis optica spectrum disorder (NMOSD), and idiopathic transverse myelitis (TM). Dr. Levy is also the principal investigator (PI) on numerous patient studies and drug trials for new and improved treatments for these disorders. In 2022, Dr. Levy became the lead principal investigator for the two worldwide clinical trials in MOG antibody disease. In the lab, Dr. Levy's research focuses on the development of animal models of NMO and MOG with the goal of tolerization as a sustainable long-term treatment. Dr. Levy has more than 200 peer-reviewed research articles, reviews and editorials, and 3 patents covering NMO tolerization therapy, TM diagnostics, and stem cell regeneration approaches.

On Food Talk with Dani Nierenberg, Dani speaks with Jessica Fanzo, a Professor of Food Policy & Climate at the Johns Hopkins School of Advanced International Studies Europe. They discuss whether decisionmakers' awareness of the links between food, agriculture and climate is growing, the amazing potential of food systems transformation in urban centers, and what Fanzo believes would be a "game changer for humanity." Plus, organizations step up to help the victims of Venezuela's earthquakes, heatwaves hit Europe, 4.7 million people lose access to SNAP, and new research shows that an investment in food and agriculture systems can create millions of jobs in the Middle East, North Africa, Afghanistan and Pakistan by 2050. While you're listening, subscribe, rate, and review the show; it would mean the world to us to have your feedback. You can listen to "Food Talk with Dani Nierenberg" wherever you consume your podcasts.

In this episode, Haylie Pomroy is joined by Dr. Craig P. Tanio to explore the evolving field of brain health, including current approaches to supporting patients with chronic illnesses, the importance of multimodal interventions, and the value of partnering with healthcare providers who advocate for their patients. Dr. Tanio shares his journey into caring for individuals with complex chronic conditions through a "clinic without walls" approach, explains why patients should actively evaluate and engage with their healthcare providers, and discusses the importance of finding clinicians who foster trust, compassion, and hope. Together, they also examine how data-driven insights can enhance personalized care and highlight strategies that may support cognitive function and long-term brain health. Discover how patient-centered care, innovative approaches, and brain health strategies can help improve outcomes for those living with chronic illness here on Fast Metabolism Matters. If your body feels like it's running on empty, overburdened, or just not responding the way it used to, Haylie's latest book, Toxic Overload, tells you exactly what to do. Download your free digital copy today and start understanding what your body is trying to tell you.   Free Download: Get Your Copy of Toxic Overload

Resources: Read Repositioning Guidelines to Decrease Pressure Injury in the Pediatric Intensive Care Unit: A Quality Improvement Project in the July/August 2024 issue of JWOCN and watch the accompanying video abstract. About the Speaker: Margaret Birdsong, DNP, CPNP, CWOCN, is a Pediatric Nurse Practitioner at Johns Hopkins Children's Center. Margaret has been a dedicated member of the Division of Pediatric Surgery since 2000. She has been a Certified Wound, Ostomy, and Continence Nurse (CWOCN) since 2002 and serves as the primary wound care consultant for the pediatric hospital. In 2020, she earned her Doctor of Nursing Practice (DNP) from the Johns Hopkins School of Nursing. In addition to her clinical responsibilities, she works closely with Dr. Isam Nasr in the Colorectal Center, where she is also certified in biofeedback therapy. Margaret has presented nationally on a range of topics, including general pediatric surgery, wound and ostomy care, and pediatric continence management. Her clinical and academic work focuses on improving outcomes and quality of life for pediatric patients with complex surgical and continence needs. Editing and post-production work for this episode was provided by The Podcast Consultant.

Eliot Cohen, Arleigh A. Burke Chair in Strategy at the Center for Strategic and International Studies; professor emeritus at Johns Hopkins School of Advanced International Studies, author of The Strategist: How to Think About War and Politics; and co-host of the Shield of the Republic podcast, joins School of War to discuss the recent agreement between the United States and Iran. Did the United States and Israel accomplish their objectives against Iran? What does the conflict reveal about the U.S. military's readiness for future wars? And did Trump negotiate from a position of strength, or squander one? 01:22 - Eliot Cohen on the war with Iran 03:34 - Judging Trump by outcomes 05:08 - A war 47 years in the making 06:45 - What we don't know about the air campaign 08:08 - Negotiating from strength? 09:10 - Trump's negotiating style 12:05 - Questions about America's conduct of the war 14:31 - The Strait of Hormuz becomes the objective 15:41 - Why the war ended when it did 17:25 - Trump and the nature of war 19:01 - Has Iran succeeded? 23:21 - The decline of the Iranian empire 28:09 - Why Trump got a bad deal 31:36 - Auditing the U.S. military 39:39 - Has warfare been transformed? 42:10 - What should America do next? Learn more about your ad choices. Visit megaphone.fm/adchoices

Everything looks to be going China's way: Beijing has a stranglehold on the world's critical minerals, and its high-tech manufacturing has rapidly become world-leading. Its massive trade surplus is undermining vital industries in the rest of the world. Is this part of a Chinese masterplan for world domination? The truth is a little more nuanced than that. Soumaya Keynes speaks to Jessica Chen Weiss, director of the Institute for America, China, and the Future of Global Affairs at Johns Hopkins School of Advanced International Studies. They discuss why decoupling is a “fantasy”, what “middle powers” are doing better than the US and the social and the domestic challenges that still hold China back.Subscribe to Soumaya's show on Apple, Spotify, Pocket Casts or wherever you listen.Further readingA cold peace between the US and China is good enoughPete Hegseth says US-China ties are ‘better than in years'America needs to put the renminbi back on the international agendaHosted by Soumaya Keynes. Produced by Mischa Frankl-Duval. Original music and sound design by Breen Turner. The executive producer is Manuela Saragosa.Read a transcript of this episode on FT.com Hosted on Acast. See acast.com/privacy for more information.

Jonathan Plucker, a research professor at the Johns Hopkins School of Education, and Fordham's own Alicia Anderson, policy and editorial associate, join The Education Gadfly Show to discuss new research on how little states and the federal government invest in advanced education. How much funding goes toward gifted education, AP, IB, and other advanced learning opportunities, and why is it so hard to track where those dollars go?Then, on the Research Minute, Brian Fitzpatrick examines new research on Algebra I achievement gaps and finds that many are rooted as early as third grade and grew worse during the pandemic.Recommended content:Broad support, barely funded: The paradox of advanced education in America —Jonathan Plucker, Alicia Anderson, Matthew Makel, and Shaun Dougherty for AdvanceThe Leaky Pipeline: Assessing the college outcomes of Ohio's high-achieving low-income students —Stéphane Lavertu, Thomas B. Fordham InstituteBuilding a Wider, More Diverse Pipeline of Advanced Learners —The National Working Group on Advanced EducationOhio's Lost Einsteins: The inequitable outcomes of early high achievers —Scott Imberman, Thomas B. Fordham InstituteA Widening Chasm: The Divergent Paths of High- and Low-Achieving Students in Algebra I After the Pandemic—Benjamin Backes, Michael DeArmond, Elise Dizon-Ross, Dan Goldhaber, and Alejandra Salazar, CALDER (2026)Feedback Welcome: Have ideas for improving our show? We would love to hear them. Send them to thegadfly@fordhaminstitute.org

In this episode of the AAOS Now Podcast, host Richard Schaefer, MD, FAAOS, sits down with two of orthopaedic surgery's most dedicated advocates for medical student mentorship, William Levine, MD, FAAOS, and Amiethab Aiyer, MD, FAAOS, for a candid conversation about the residency Match process.  The discussion tackles the nuts, bolts, and controversies of today's highly competitive application landscape, including how signaling helps students whittle down the number of programs they apply to, why away rotations may have gotten out of hand, and whether every student really needs to do a research year.  Drs. Levine and Aiyer share how their decades-long professional relationship helped shape their commitment to guiding the next generation of orthopaedic surgeons. They explain that mentorship is a bidirectional partnership in which the mentee must put forth more than just a desire to learn. They talk about the importance of building a diverse "board" of mentors across institutions. And they encourage students to seek out mentors, including near-peers, who have their “finger on the pulse” of the rapidly-evolving Match process.  The episode closes with a candid challenge to prospective applicants: Before attempting to match into orthopaedic surgery, ask yourself why you want to be an orthopaedic surgeon. According to Dr. Levine, mentors should require all of their mentees to answer that question — and if the answer is iffy, encourage them to consider a different specialty.  Key Topics Covered in this Episode How the residency Match process works: from application to Match Day Building a mentorship "board": why one mentor isn't enough and how to cultivate relationships across institutions Mentorship as a bidirectional partnership: what mentees must bring to the relationship The origin of OrthoMentor: how Drs. Levine and Aiyer began collaborating to fill a nationwide advising void and how students at institutions with limited advising resources can still access current, accurate guidance Signaling and application caps: understanding the data behind limiting program applications (yes, 100 applications is too many) Away rotations: how many to do and why cohort strategy matters when applying Research years: when they help, when they don't, and what to look for in a productive year Schools without home programs: unique challenges and where to find current guidance Pursuing the right path: why students should reflect on their motivations before pursuing a career in orthopaedic surgery, and why where you train isn't as important as what you do with the opportunity About Our Guests William N. Levine, MD, FAAOS, the Frank E. Stinchfield Professor and Chair, Department of Orthopaedic Surgery, Columbia University College of Physicians and Surgeons; Chief of the Orthopaedics Service at New York-Presbyterian/Columbia University Medical Center; and Editor-in-Chief Emeritus, Journal of the American Academy of Orthopaedic Surgeons Amiethab Aiyer, MD, FAAOS, Division Chief of foot and ankle surgery and Associate Professor, Department of Orthopaedic Surgery, Johns Hopkins School of Medicine; Deputy Editor, Journal of the American Academy of Orthopaedic Surgeons

In this episode of the AAOS Now Podcast, host Richard Schaefer, MD, FAAOS, sits down with two of orthopaedic surgery's most dedicated advocates for medical student mentorship, William Levine, MD, FAAOS, and Amiethab Aiyer, MD, FAAOS, for a candid conversation about the residency Match process.  The discussion tackles the nuts, bolts, and controversies of today's highly competitive application landscape, including how signaling helps students whittle down the number of programs they apply to, why away rotations may have gotten out of hand, and whether every student really needs to do a research year.  Drs. Levine and Aiyer share how their decades-long professional relationship helped shape their commitment to guiding the next generation of orthopaedic surgeons. They explain that mentorship is a bidirectional partnership in which the mentee must put forth more than just a desire to learn. They talk about the importance of building a diverse "board" of mentors across institutions. And they encourage students to seek out mentors, including near-peers, who have their “finger on the pulse” of the rapidly-evolving Match process.  The episode closes with a candid challenge to prospective applicants: Before attempting to match into orthopaedic surgery, ask yourself why you want to be an orthopaedic surgeon. According to Dr. Levine, mentors should require all of their mentees to answer that question — and if the answer is iffy, encourage them to consider a different specialty.  Key Topics Covered in this Episode How the residency Match process works: from application to Match Day Building a mentorship "board": why one mentor isn't enough and how to cultivate relationships across institutions Mentorship as a bidirectional partnership: what mentees must bring to the relationship The origin of OrthoMentor: how Drs. Levine and Aiyer began collaborating to fill a nationwide advising void and how students at institutions with limited advising resources can still access current, accurate guidance Signaling and application caps: understanding the data behind limiting program applications (yes, 100 applications is too many) Away rotations: how many to do and why cohort strategy matters when applying Research years: when they help, when they don't, and what to look for in a productive year Schools without home programs: unique challenges and where to find current guidance Pursuing the right path: why students should reflect on their motivations before pursuing a career in orthopaedic surgery, and why where you train isn't as important as what you do with the opportunity About Our Guests William N. Levine, MD, FAAOS, the Frank E. Stinchfield Professor and Chair, Department of Orthopaedic Surgery, Columbia University College of Physicians and Surgeons; Chief of the Orthopaedics Service at New York-Presbyterian/Columbia University Medical Center; and Editor-in-Chief Emeritus, Journal of the American Academy of Orthopaedic Surgeons Amiethab Aiyer, MD, FAAOS, Division Chief of foot and ankle surgery and Associate Professor, Department of Orthopaedic Surgery, Johns Hopkins School of Medicine; Deputy Editor, Journal of the American Academy of Orthopaedic Surgeons

The Mercantilist Restoration - https://anthonyfatseas.substack.com/p/the-mercantilist-restoration-howInterview recorded - 22nd of May, 2026On this episode of the WTFinance podcast I had the pleasure of welcoming back Professor Vali Nasr. Vali Nasr is a Professor at the Johns Hopkins School of Advanced International Studies, a senior adviser at the Center for Strategic and International Studies, and one of the most authoritative voices on Iran, having advised American policymakers and diplomats on the country for decades. He is also the author of Iran's Grand Strategy: A political history.During our conversation we spoke about the current situation in the Middle East, what has led up to this conflict, Iran's surprising resilience, their grand strategy, potential escalation, reshaping the Middle East and more. I hope you enjoy!0:00 - Introduction3:05 - Lead up to war5:48 - Surprised about escalation8:38 - Iran resilience10:48 - Iran's Grand Strategy13:18 - October 6th impact16:23 - Conflict resolution20:09 - Military escalation24:11 - How have views changed?28:17 - Iranian proxies over?29:47 - US withdrawing from Middle East?34:11 - Guerrilla warfare35:25 - One message to takeaway? Vali Nasr is the Majid Khadduri Professor of International Affairs and Middle East Studies at the Johns Hopkins University School of Advanced International Studies (SAIS), and Non-Resident Senior Advisor in the Middle East Program at CSIS. He served as the eighth Dean of Johns Hopkins SAIS between 2012 and 2019 and served as Senior Advisor to U.S. Special Representative for Afghanistan and Pakistan, Ambassador Richard Holbrooke between 2009 and 2011.Professor Nasr is the author of Iran's Grand Strategy: A Political History, The Dispensable Nation: American Foreign Policy in Retreat; Forces of Fortune: The Rise of a New Middle Class and How it Will Change Our World; The Shia Revival: How Conflicts within Islam will Shape the Future; Democracy in Iran: History and the Quest for Liberty; Islamic Leviathan, Islam and the Making of State Power; Mawdudi and the Making of Islamic Revivalism; Vanguard of Islamic Revolution: Jama'at-i Islami of Pakistan, and co-author of How Sanctions Work: Iran and the Impact of Economic Warfare; as well as numerous articles in scholarly journals and commentary in Financial Times, Foreign Affairs, Foreign Policy, New York Times, Washington Post, and Wall Street Journal. He has advised senior American policymakers, world leaders, and businesses, including the President, Secretary of State, senior members of the Congress, and presidential campaigns. He has written for New York Times, Foreign Affairs, Financial Times, Wall Street Journal, and The Washington Post, among others.Vali Nasr - X - https://x.com/vali_nasrBook - https://www.amazon.co.uk/Irans-Grand-Strategy-Political-History/dp/0691268924/WTFinance -Spotify - https://open.spotify.com/show/67rpmjG92PNBW0doLyPvfniTunes -https://podcasts.apple.com/us/podcast/wtfinance/id1554934665?uo=4LinkedIn - https://www.linkedin.com/in/anthony-fatseas-761066103/Twitter - https://twitter.com/AnthonyFatseas

This episode explores the art and responsibility of mentoring medical students in orthopaedic surgery, featuring guest Amiethab Aiyer, MD, FAAOS.  Dr. Aiyer, Division Chief of Foot and Ankle Surgery in the Department of Orthopaedic Surgery at Johns Hopkins School of Medicine, Deputy Editor of the Journal of the American Academy of Orthopaedic Surgeons, and founder of the widely followed OrthoMentor Instagram channel, joins host Ellen Lutnick, MD, AAOS Resident Assembly Executive Committee Chair, for a candid conversation about mentorship at every stage of training. Dr. Aiyer shares his own unexpected path to orthopaedics, pivoting late in medical school after originally planning a career in pediatric oncology, and reflects on how that experience shaped his deep commitment to making himself accessible to students navigating similar crossroads. He draws a meaningful distinction between mentorship, advising, and coaching, and offers practical guidance on how trainees and attendings alike can be more intentional about building those relationships. Listeners will also hear his perspective on what makes a good mentee, the growing role of social media and orthopaedic organizations in connecting students with resources, and why availability and accessibility are among the most important qualities a mentor can offer. Guest: Amiethab Aiyer, MD, FAAOS, Division Chief of Foot and Ankle Surgery and Associate Professor, Department of Orthopaedic Surgery, Johns Hopkins School of Medicine; Deputy Editor, Journal of the American Academy of Orthopaedic Surgeons Host: Ellen Lutnick, MD, AAOS Resident Assembly Executive Committee Chair

The "Community Meets Clinic" podcast series introduces clinicians and healthcare personnel specializing in rare neuroimmune disorders. In this episode hosted by Krissy Dilger of SRNA, we met Dr. Benjamin Greenberg of the UT Southwestern Medical Center. He outlined his translational research, including the Q Study, a Phase 1 trial assessing the safety and feasibility of transplanting human glial restricted progenitor cells into the spinal cord of people who have been diagnosed with transverse myelitis (TM) [05:49]. He also described research on immune-remodeling therapies for NMO aimed at reducing long-term immunosuppression. Dr. Greenberg illustrated multidisciplinary care at UT Southwestern and Children's Medical Center, emphasized options for second opinions and clinician-to-clinician remote consultation, and shared hopes for nervous system repair trials and curative immune therapies [07:18]. You can view Dr. Benjamin Greenberg's medical profile here:https://utswmed.org/doctors/benjamin-greenberg/Benjamin M. Greenberg, MD, MHS is a Professor and the Cain Denius Scholar in Mobility Disorders in the Department of Neurology [https://utswmed.org/why-utsw/departments/neurology/] at UT Southwestern Medical Center in Dallas, Texas. He currently serves as the Vice Chair of Translational Research and Strategic Initiatives for the Department of Neurology. He is also the interim Director of the Multiple Sclerosis Center [https://utswmed.org/locations/aston/multiple-sclerosis-and-neuroimmunology-clinic/] and the Director of the Neurosciences Clinical Research Center. In addition, he serves as Director of the Transverse Myelitis and Neuromyelitis Optica Program and the Pediatric Demyelinating Disease Program at Children's Medical Center [https://www.childrens.com/specialties-services/specialty-centers-and-programs/neurology/demyelinating-disease-program].Dr. Greenberg earned his medical degree at Baylor College of Medicine before completing an internal medicine internship at Chicago's Rush Presbyterian-St. Luke's Medical Center. He performed his neurology residency at the Johns Hopkins School of Medicine. He also holds an M.H.S. in molecular microbiology and immunology from the Bloomberg School of Public Health, as well as a bachelor's degree in the history of medicine – both from Johns Hopkins. Prior to his recruitment to UT Southwestern in 2009, Dr. Greenberg was on the faculty of the Johns Hopkins Division of Neuroimmunology, serving as the Director of the Encephalitis Center and Co-Director of the nation's first dedicated Transverse Myelitis Center.Dr. Greenberg splits his clinical time between adult and pediatric patients at William P. Clements Jr. and Zale Lipshy University Hospitals, Parkland, and Children's Medical Center. His research focuses on better diagnosing, prognosticating, and treating demyelinating diseases and nervous system infections. He also coordinates clinical trials to evaluate new treatments to prevent neurologic damage and restore function to affected patients.00:00 Welcome and Guest Intro01:41 Path to Neurology03:50 Why Neuroimmunology05:49 Research Focus and Trials07:18 Clinic Team and Referrals10:31 Self Care and Hobbies12:17 How the Clinic Can Help14:16 Hope for Future Therapies15:56 Wrap Up

Krissy Dilger of SRNA hosted Dr. Benjamin Greenberg of UT Southwestern to share updates on the Q Study, a Phase 1 trial assessing the safety and feasibility of transplanting human glial restricted progenitor cells into the spinal cord of people who have been diagnosed with transverse myelitis (TM). Dr. Greenberg cautioned the audience against stem cell tourism [00:03:03]. He described the decades-long development of the cell line and safety monitoring for this study [00:01:35]. He reported no safety signals prompting a trial pause and noted the FDA-approved expansion of eligibility from non-ambulatory participants to those who can walk with assistance, while efficacy results were not yet being shared [00:08:31]. Finally, Dr. Greenberg outlined potential next steps, including Phase 2 studies and expanded populations (e.g., MOGAD and NMOSD diagnoses), as well as future targets [00:17:02].Benjamin M. Greenberg, MD, MHS is a Professor and the Cain Denius Scholar in Mobility Disorders in the Department of Neurology [https://utswmed.org/why-utsw/departments/neurology/] at UT Southwestern Medical Center in Dallas, Texas. He currently serves as the Vice Chair of Translational Research and Strategic Initiatives for the Department of Neurology. He is also the interim Director of the Multiple Sclerosis Center [https://utswmed.org/locations/aston/multiple-sclerosis-and-neuroimmunology-clinic/] and the Director of the Neurosciences Clinical Research Center. In addition, he serves as Director of the Transverse Myelitis and Neuromyelitis Optica Program and the Pediatric Demyelinating Disease Program at Children's Medical Center [https://www.childrens.com/specialties-services/specialty-centers-and-programs/neurology/demyelinating-disease-program].Dr. Greenberg earned his medical degree at Baylor College of Medicine before completing an internal medicine internship at Chicago's Rush Presbyterian-St. Luke's Medical Center. He performed his neurology residency at the Johns Hopkins School of Medicine. He also holds an M.H.S. in molecular microbiology and immunology from the Bloomberg School of Public Health, as well as a bachelor's degree in the history of medicine – both from Johns Hopkins. Prior to his recruitment to UT Southwestern in 2009, Dr. Greenberg was on the faculty of the Johns Hopkins Division of Neuroimmunology, serving as the Director of the Encephalitis Center and Co-Director of the nation's first dedicated Transverse Myelitis Center.Dr. Greenberg splits his clinical time between adult and pediatric patients at William P. Clements Jr. and Zale Lipshy University Hospitals, Parkland, and Children's Medical Center. His research focuses on better diagnosing, prognosticating, and treating demyelinating diseases and nervous system infections. He also coordinates clinical trials to evaluate new treatments to prevent neurologic damage and restore function to affected patients.00:00 Welcome and Guest Intro01:35 Origins of Q Study02:46 Getting Cells Into Cord04:49 Phase One Trial Design06:31 Safety and Efficacy Measures08:31 Eligibility Expanded Criteria11:39 Screening and Selection14:05 Travel and Site Logistics15:15 Early Safety Findings17:02 Next Steps After Phase One19:01 Beyond Idiopathic Myelitis23:07 Damage Differences by Disease25:20 Optic Nerve and Brain Targets27:29 Expected Outcomes and Vision28:58 Final Thanks

Today on the show, President Trump is back from two days of high-level talks in China. Matt Pottinger, the deputy national security advisor in the first Trump administration, and Jessica Chen Weiss, professor of China Studies at Johns Hopkins School of Advanced International Studies, join the show to discuss the summit and what it means for Taiwan. Next, Fareed speaks with Jason Furman, professor at Harvard Kennedy School and former chair of the Council of Economic Advisers under President Obama. They discuss why the stock market continues to rise even while inflation spikes in the midst of the Iran war, and what Furman expects from new Fed Chair Kevin Warsh. Finally, a recent poll shows 70% of American adults under the age of 50 now hold an unfavorable view of Israel. Fareed discusses with Israeli-American historian Omer Bartov who has a new book out, “Israel: What Went Wrong.” GUESTS: Jessica Chen Weiss (@jessicacweiss), Matt Pottinger, Jason Furman (@jasonfurman), Omer Bartov (@bartov_omer) Learn more about your ad choices. Visit podcastchoices.com/adchoices

Healing begins long before a diagnosis, it starts with feeling seen, heard, and cared for. Pediatrician, mentor, and health equity advocate Dr. Tyler Smith shares a heartfelt conversation about caring for children, supporting families, and leading with purpose. From discovering her passion for pediatrics at a young age to mentoring the next generation of healthcare leaders, Dr. Tyler reflects the importance of representation, mental health, community, and whole-person care. This episode is a reminder that healing goes beyond medicine. It begins with listening, compassion, advocacy, and creating spaces where people feel seen, supported, and valued.  Key Takeaways:   Your "why" helps you stay grounded, prevent burnout, and reconnect with purpose.   Healthy children thrive when families, communities, and healthcare providers work together.   Mental health conversations should begin with listening, validating, and checking in consistently.  Representation and advocacy in healthcare matter for trust, safety, and better outcomes.   Small moments of connection, joy, and mentorship can create generational impact.   We couldn't highlight incredible stories like this without the support of our sponsor, CommunityAmerica Credit Union. Thank you for helping us promote connection, well-being, and stronger communities. If you're looking for trusted financial wellbeing resources, we invite you to connect with their team and take the next step toward greater financial confidence.  About Dr. Tyler Smith:  Tyler K. Smith, MD, MPH, FAAP is a board-certified general pediatrician. She is a graduate of Hampton University and the University of South Carolina School of Medicine. Dr. Smith completed General Pediatric Residency training at the University of Maryland Medical Center. She also completed General Academic Pediatric Fellowship training at Johns Hopkins School of Medicine where she earned a Master's degree in Public Health from Johns Hopkins Bloomberg School of Public Health. Her professional interests include advocacy, diversity, equity, inclusion, justice; health care disparities and inequities; marginalized and minoritized populations; resource-limited communities; mentorship, coaching, and sponsorship; medical education; leadership; and physician wellness. Dr. Smith currently serves as Associate Dean of Inclusive Excellence in the Office of the Learning Environment and Associate Professor of Pediatrics at the University of Missouri-Kansas City School of Medicine and Clinical Assistant Professor of Pediatrics at the University of Kansas School of Medicine. She is the Fellowship Director for the Academic General Pediatrics Fellowship Program at Children's Mercy Kansas City.  Connect with Dr. Tyler Smith at:  https://www.childrensmercy.org/professional-education/training-programs/fellowship/academic-general-pediatrics/   https://med.umkc.edu/departments/administrative-offices-departments/ole/inclusive-excellence/  Connect with Dr. Michelle and Bayleigh at:  https://smallchangesbigshifts.com  hello@smallchangesbigshifts.com  https://www.linkedin.com/company/smallchangesbigshifts  https://www.facebook.com/SmallChangesBigShifts  https://www.instagram.com/smallchangesbigshiftsco  https://www.youtube.com/@smallchangesbigshiftsco    Thanks for listening!  Thanks so much for listening to our podcast! If you enjoyed this episode and think that others could benefit from listening, please share it using the social media buttons on this page.  Do you have some feedback or questions about this episode? Leave a comment in the section below!  Subscribe to the podcast  If you would like to get automatic updates of new podcast episodes, you can subscribe to the podcast on Apple Podcasts or Stitcher. You can also subscribe in your favorite podcast app.  Leave us an Apple Podcasts review  Ratings and reviews from our listeners are extremely valuable to us and greatly appreciated. They help our podcast rank higher on Apple Podcasts, which exposes our show to more awesome listeners like you. If you have a minute, please leave an honest review on Apple Podcasts. 

The Beijing Auto Show is now the world's largest auto show — and its most important. It's where China's automakers show off their new innovations and newest models to a huge audience of domestic consumers and global influencers. As one attendee observed, there were more EV models in one room of the show than there are available for sale in the entire U.S. car market.So what was it like to be there in person? On today's episode of Shift Key, Rob talks with Kate Logan, the director of the China Climate Hub and Climate Diplomacy at the Asia Society Policy Institute; and Jeremy Wallace, the A. Doak Barnett Professor of China Studies at Johns Hopkins School of Advanced International Studies.Jeremy and Kate attended this year's show and left with some strong impressions. They also chat with Rob about whether China has solved the EV charging problem, what tech was most impressive (and what was absent) from the expo, and how American policymakers should work with China's world-leading battery and EV manufacturing firms. Shift Key is hosted by Robinson Meyer, the founding executive editor of Heatmap News.You can find a full transcript of the episode here.Mentioned:WSJ: Chinese EVs can already be seen in the US… in El PasoThe new Carnegie Mellon report: An Industrial Strategy for Ranking Risk and Opportunity in Energy & AI Supply ChainsBloomberg on the Ford and CATL dealJeremy's recent work in Heatmap: China Can't Decide If It Wants to Be the World's First ‘Electrostate'--This episode of Shift Key is sponsored by ...Heatmap Pro brings all of our research, reporting, and insights down to the local level. The software platform tracks all local opposition to clean energy and data centers, forecasts community sentiment, and guides data-driven engagement campaigns. Book a demo today to see the premier intelligence platform for project permitting and community engagement.Music for Shift Key is by Adam Kromelow. Hosted on Acast. See acast.com/privacy for more information.

How prepared are we for high-consequence infectious diseases? In this episode of the 5 Second Rule Podcast, hosts Jess Fargher and Kelly Holmes dive deep into infection prevention strategies and emergency preparedness with Carrie Billman, a seasoned expert. They discuss the critical need for healthcare professionals to understand high-consequence infectious diseases, the role of robust protocols, and the importance of communication and training. Tune in to discover the insights that could save lives in future outbreaks! Hosted by: Kelly Holmes and Jess Fargher About our Guest: Carrie Billman, MHPE, RN, CIC Carrie Billman MHPE, RN, CIC is a senior Infection Preventionist who serves as the Director of Education and Training for the Biocontainment Unit (BCU) at the Johns Hopkins Special Pathogen Center where she leads the design and implementation of training curriculum to prepare clinicians at Johns Hopkins and throughout HHS Region 3 to safely care for patients requiring high-level isolation. She leads the BCU Infection Prevention team and trained observer program and serves as an adjunct faculty for the Johns Hopkins School of Public Health. 

Today Pierce Salguero sit down with Prof. Jeff Kripal, noted scholar of religion at Rice University, to talk about extraordinary, mysterious, and “impossible” experiences. This is a conversation I've been waiting a few years to have. Together we explore what you can or can't talk about in the humanities — and what we risk when we break the rules. Along the way, we touch on paranormal phenomena, epistemological pluralism, conspiracy theories, Plato's cave, and why no one dresses up as a humanities professor for Halloween. If you want to hear scholars and practitioners engaging in deep conversations about the dark side of Asian religions and medicines, then subscribe to Black Beryl wherever you get your podcasts. Enjoy the show! Resources related to this conversation: Jeff Kripal's website Archives of the Impossible & Conferences Pierce Salguero, "Secret Lives of Buddhist Studies Scholars" (2024) Pierce Salguero, "The Fractal of Humanities" (2021) Peter Sjöstedt-Hughes, "On the need for metaphysics in psychedelic therapy and research" (2023) Jeff Kripal, The Flip (2020) Jeff Kripal, Secret Body (2019) Commonweal Podcast Subscribe here to unlock our members-only benefits, including: PDF of the introduction of Jeff's book, How to Think Impossibly: About Souls, UFOs, Time, Belief, and Everything Else (2024) Pierce Salguero is a transdisciplinary scholar of health humanities who is fascinated by historical and contemporary intersections between Buddhism, medicine, and crosscultural exchange. He has a Ph.D. in History of Medicine from the Johns Hopkins School of Medicine and teaches Asian history, medicine, and religion at Penn State University's Abington College, located near Philadelphia. See here. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

What can we do to deal with this funding crisis in academic health and get through it with balance, equanimity and resilience? Mindfulness-based stress reduction and other mental health aspects that can help deal with the funding challenges in academic health are explored in this week's edition of the Faculty Factory Podcast with our guest Neda Gould, PhD. "It's tapping into our creativity and also recognizing that we will also get through this. It's just how can we get through it with some balance and equanimity and resilience?" Dr. Gould said. In this funding climate, with job security concerns top of mind, there are resources along the lines of support groups and other available tools to explore because we all have to keep fortifying forward. No one has all the answers, but Dr. Gould takes us through many small changes we can work on to continue to enjoy life despite these external stressors. Dr. Gould is Director of the Mindfulness Program and Associate Director of the Bayview Anxiety Disorders Clinic, both in the Department of Psychiatry and Behavioral Sciences at the Johns Hopkins School of Medicine. About The Johns Hopkins Mindfulness Program: https://www.hopkinsmedicine.org/psychiatry/specialty-areas/mindfulness In March 2020, Dr. Gould joined the Faculty Factory Podcast (remotely, of course) and delivered two very memorable episodes to help our community cope with the emerging anxiety of the time, for which we are forever grateful. Along with her most recent podcast interview with us before today, you can revisit all of her interviews with us: Self-Care Tools for Stressful Times with Neda Gould, PhD Tips for Dealing with Uncertainty in Uncertain Times with Neda Gould, PhD  Guided Meditation with Neda Gould, PhD

Today Pierce Salguero sit down with Prof. Jeff Kripal, noted scholar of religion at Rice University, to talk about extraordinary, mysterious, and “impossible” experiences. This is a conversation I've been waiting a few years to have. Together we explore what you can or can't talk about in the humanities — and what we risk when we break the rules. Along the way, we touch on paranormal phenomena, epistemological pluralism, conspiracy theories, Plato's cave, and why no one dresses up as a humanities professor for Halloween. If you want to hear scholars and practitioners engaging in deep conversations about the dark side of Asian religions and medicines, then subscribe to Black Beryl wherever you get your podcasts. Enjoy the show! Resources related to this conversation: Jeff Kripal's website Archives of the Impossible & Conferences Pierce Salguero, "Secret Lives of Buddhist Studies Scholars" (2024) Pierce Salguero, "The Fractal of Humanities" (2021) Peter Sjöstedt-Hughes, "On the need for metaphysics in psychedelic therapy and research" (2023) Jeff Kripal, The Flip (2020) Jeff Kripal, Secret Body (2019) Commonweal Podcast Subscribe here to unlock our members-only benefits, including: PDF of the introduction of Jeff's book, How to Think Impossibly: About Souls, UFOs, Time, Belief, and Everything Else (2024) Pierce Salguero is a transdisciplinary scholar of health humanities who is fascinated by historical and contemporary intersections between Buddhism, medicine, and crosscultural exchange. He has a Ph.D. in History of Medicine from the Johns Hopkins School of Medicine and teaches Asian history, medicine, and religion at Penn State University's Abington College, located near Philadelphia. See here. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/buddhist-studies

Today Pierce Salguero sit down with Prof. Jeff Kripal, noted scholar of religion at Rice University, to talk about extraordinary, mysterious, and “impossible” experiences. This is a conversation I've been waiting a few years to have. Together we explore what you can or can't talk about in the humanities — and what we risk when we break the rules. Along the way, we touch on paranormal phenomena, epistemological pluralism, conspiracy theories, Plato's cave, and why no one dresses up as a humanities professor for Halloween. If you want to hear scholars and practitioners engaging in deep conversations about the dark side of Asian religions and medicines, then subscribe to Black Beryl wherever you get your podcasts. Enjoy the show! Resources related to this conversation: Jeff Kripal's website Archives of the Impossible & Conferences Pierce Salguero, "Secret Lives of Buddhist Studies Scholars" (2024) Pierce Salguero, "The Fractal of Humanities" (2021) Peter Sjöstedt-Hughes, "On the need for metaphysics in psychedelic therapy and research" (2023) Jeff Kripal, The Flip (2020) Jeff Kripal, Secret Body (2019) Commonweal Podcast Subscribe here to unlock our members-only benefits, including: PDF of the introduction of Jeff's book, How to Think Impossibly: About Souls, UFOs, Time, Belief, and Everything Else (2024) Pierce Salguero is a transdisciplinary scholar of health humanities who is fascinated by historical and contemporary intersections between Buddhism, medicine, and crosscultural exchange. He has a Ph.D. in History of Medicine from the Johns Hopkins School of Medicine and teaches Asian history, medicine, and religion at Penn State University's Abington College, located near Philadelphia. See here. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/psychology

Today Pierce Salguero sit down with Prof. Jeff Kripal, noted scholar of religion at Rice University, to talk about extraordinary, mysterious, and “impossible” experiences. This is a conversation I've been waiting a few years to have. Together we explore what you can or can't talk about in the humanities — and what we risk when we break the rules. Along the way, we touch on paranormal phenomena, epistemological pluralism, conspiracy theories, Plato's cave, and why no one dresses up as a humanities professor for Halloween. If you want to hear scholars and practitioners engaging in deep conversations about the dark side of Asian religions and medicines, then subscribe to Black Beryl wherever you get your podcasts. Enjoy the show! Resources related to this conversation: Jeff Kripal's website Archives of the Impossible & Conferences Pierce Salguero, "Secret Lives of Buddhist Studies Scholars" (2024) Pierce Salguero, "The Fractal of Humanities" (2021) Peter Sjöstedt-Hughes, "On the need for metaphysics in psychedelic therapy and research" (2023) Jeff Kripal, The Flip (2020) Jeff Kripal, Secret Body (2019) Commonweal Podcast Subscribe here to unlock our members-only benefits, including: PDF of the introduction of Jeff's book, How to Think Impossibly: About Souls, UFOs, Time, Belief, and Everything Else (2024) Pierce Salguero is a transdisciplinary scholar of health humanities who is fascinated by historical and contemporary intersections between Buddhism, medicine, and crosscultural exchange. He has a Ph.D. in History of Medicine from the Johns Hopkins School of Medicine and teaches Asian history, medicine, and religion at Penn State University's Abington College, located near Philadelphia. See here. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/religion

On this episode of Virtual Sentiments, Kristen Collins speaks with Henry Farrell about AI, democracy, and political economy. Farrell argues that large language models are best understood not as emerging individual intelligences, but as “social technologies” that process and reorganize vast stores of human cultural information, much like markets, bureaucracies, and democracies process knowledge. The conversation explores deliberative democracy, civil society, Silicon Valley, AI regulation, and the risks of treating politics as an optimization problem. Farrell emphasizes the messiness of democratic life as essential to resisting authoritarianism and building a better future.Henry Farrell is the SNF Agora Professor of International Affairs at Johns Hopkins School of Advanced International Studies. He is the author of various books, including Underground Empire: How America Weaponized the World Economy (Henry Holt and Co., 2023) and Of Privacy and Power: The Transatlantic Fight over Freedom and Security (Princeton University Press, 2019), both coauthored with Abraham Newman, as well as The Political Economy of Trust: Institutions, Interests, and Inter-Firm Cooperation in Italy and Germany (Cambridge University Press, 2009).**This episode was recorded on January 7, 2026**Show Notes:Virtual Sentiments | State Capture and the Meaning of Democracy with Samuel BaggHenry Farrell's Substack, Programmable MutterHenry Farrell and Abraham Newman, The Enshittification of American Power (Wired, 2025)Henry Farrell and Hahrie Han, AI and Democratic Publics (Knight First Amendment Institute, 2025)Farrell, Gopnik, Shalizi, and Evans, Large AI models are cultural and social technologies (Science, 2025)Farrell, Mercier, and Schwartzberg, Analytical Democratic Theory: A Microfoundational Approach (APSR, 2022)Farrell, Where Trump is Vulnerable and How to Act on It (New York Times, 2025)Farrell, The Same Old Fantasies Behind AI and New Technology (Lawfare, 2025)Herbert A. Simon, The Sciences of the Artificial (The MIT Press, 1970)F.A. Hayek, The Use of Knowledge in Society (Liberty Fund, 2013)Cosma Shalizi, The Singularity in Our Past Light-Cone (Three-Toed Sloth, 2010)Andrew Lentini, Reimagining Democracy in the Age of AI (SNF Agora, 2024)Hugo Mercier and Dan Sperber, Why do humans reason? Arguments for an argumentative theory (BBS, 2011)North, Wallis, and Weingast, Violence and Social Orders (Cambridge University Press, 2009)Cory Doctorow, The Bezzle: A Martin Hench Novel (Tor Books, 2025)If you like the show, please subscribe, leave a 5-star review, and tell others about the show! We're available on Apple Podcasts, Spotify, Amazon Music, and wherever you get your podcasts.Follow the Hayek Program on Twitter: @HayekProgramLearn more about Academic & Student ProgramsFollow the Mercatus Center on Twitter: @mercatus

A nurse in a Baltimore laundromat might be testing one of the most important ideas in American health care: what if care started before you ever needed the emergency room? Organizations from NPR to the Milbank Memorial Fund are closely watching the Neighborhood Nursing program that the top-ranked Johns Hopkins School of Nursing has brought […] The post The Nurse at the Laundromat: An Innovative Model appeared first on Healthy Communities Online.

This episode unpacks three enduring pillars that have defined U.S. foreign policy from the nation's founding to today: ideology, economic statecraft, and democratic accountability.   Host: James M. Lindsay, Mary and David Boies Distinguished Senior Fellow in U.S. Foreign Policy, CFR   Guest: Michael Mandelbaum, Professor Emeritus of American Foreign Policy at the Johns Hopkins School of Advanced International Studies; Author, The American Way of Foreign Policy: Ideology, Economics, Democracy   We Discuss: Whether the United States can be said to have a coherent foreign policy "personality". How geographic and geopolitical advantages have historically enabled a more ideological U.S. foreign policy than most countries can afford. Whether ideology in U.S. foreign policy represents genuine conviction or merely a veneer for self-interest.  What the post-Cold War era reveals as the "golden age of foreign policy of ideas”. What drives the persistent American tendency toward economic statecraft, sanctions, and “mirror imaging”. How public opinion, interest groups, political parties, and elections influence foreign policy decisionmaking. Whether President Trump's foreign policy fits within—or represents a departure from—the three enduring American traditions in U.S. foreign policy.   Mentioned on the Episode:   The American Way of Foreign Policy: Ideology, Economics, Democracy by Michael Mandelbaum (Oxford University Press, 2025)   Embargo Act of 1807   George W. Bush, Second Inaugural Address, January 20, 2005   Vice President JD Vance, Remarks at the Munich Security Conference, February 14, 2025   Secretary of State Marco Rubio, Remarks at the Munich Security Conference, February 14, 2026   For an episode transcript and show notes, visit The President's Inbox at: https://www.cfr.org/podcasts/presidents-inbox/how-to-build-an-american-foreign-policy   Opinions expressed on The President's Inbox are solely those of the host or guests, not of CFR, which takes no institutional positions on matters of policy.

On this episode, we are joined by Jyo Supnekar, an occupational therapist and certified hand therapist who recently traveled to Nepal to share her expertise with therapists and other healthcare workers. Jyo shares with us the work that the mission team did in delivering medical care to patients in the hospital, as well as the education that was provided to local therapists. Jyo Supnekar, OTR/L, OTD, CHT, COMT, CLT is a Clinical Specialist at Johns Hopkins. She graduated in 1986 from the University of Mumbai, India, with a master's in occupational therapy. She has practiced in the United States since 1989 and has worked as a Certified Hand Therapist since 1998. She has a Post Professional Doctorate in Occupational Therapy and a Certification in Orthopedic Manual Therapy- the UE track from IAOM-US. She has an NDT certification for adult hemiplegia, a Lymphedema Certification and a Certificate in Advance Study of Hand and Upper Quarter Rehabilitation from Drexel University. From 2017- 2023, she established and served as the founding director of the hand therapy fellowship at Johns Hopkins. She has been an educator for fieldwork students and hand therapy fellows for numerous years. She has presented numerous times nationally and a few times internationally. She serves as a board member for the AOTA Fellowship Programs Review Committee and is an instructor for the Johns Hopkins School of Medicine.The views and opinions expressed in the Hands in Motion podcast are those of the guests and do not necessarily reflect the official policy or position of ASHT. Appearance on the podcast does not imply endorsement of any products, services or viewpoints discussed.

Subscribe now for early access, ad-free listening, and bonus content! HAIH Premium subscribers got this episode (with no ads!) on Thursday, April 23. When he took power 25 years ago, Russian President Vladimir Putin wanted to turn his country into a Great Power again, after it had endured a decade of poverty and humiliation following the collapse of the Soviet Union. But Russia is on the sidelines as wars and blockades in the Greater Middle East roil the global order. Yes, Russia has reportedly assisted Iran with satellite targeting intelligence, and its economy may benefit from the bump in oil prices. But Moscow is in no position to provide robust military assistance to its "strategic partner" Iran, and none of its representatives have been invited to the peace talks in Islamabad. Historian Sergey Radchenko explains why Russian influence is essentially irrelevant in a region where it once exerted an important presence. Sergey Radchenko teaches history at the Johns Hopkins School of Advanced International Studies. He is the author of To Run the World: The Kremlin's Cold War Bid for Global Power. Further reading: Putin's Persian Problem by Sergey Radchenko (Foreign Policy)

Frederick S. Barrett, director of the Center for Psychedelic and Consciousness Research at Johns Hopkins School of Medicine and professor in the Neuropsychopharmacology of Consciousness in the department of Psychiatry and Behavioral Sciences, talks about the use of psychedelics for mental illness and the effects of President Trump's executive order speeding up research. Photo: Tabernanthe iboga, a shrub with hallucinogenic properties, grows in Cameroon. (Credit: Marco Schmidt via Wikimedia Commons CC 2.5)

President Trump has signed an executive order in support of research into whether psychedelic drugs could be used in mental health treatments. On Today's Show:Frederick S. Barrett, director of the Center for Psychedelic and Consciousness Research at Johns Hopkins School of Medicine and professor of the Neuropsychopharmacology of Consciousness in the department of Psychiatry and Behavioral Sciences, talks about the use of psychedelics for mental illness and the effects of President Trump's executive order speeding up research.

This week I'm sharing the next installment from the terrific day-long conference convened by the Institute for America, China, and the Future of Global Affairs (ACF) at Johns Hopkins SAIS on April 3rd in Washington — "The China Debate We're Not Having: Politics, Technology, and the Road Ahead." Last week's episode featured Jessica Chen Weiss's opening remarks and the first panel, "What China Wants." This week, I've got the companion panel — "What Does the United States Want?" — which I think pairs beautifully with that first session, and which takes up a question that's arguably harder and more uncomfortable to answer. The panel is moderated by SAIS Dean James Steinberg, who served as Deputy National Security Advisor in the Clinton administration and Deputy Secretary of State under Obama — and who keeps this moving with real sharpness. He's joined by Matt Duss, Executive Vice President at the Center for International Policy, who starts things off with a bracing observation: the United States does not know what it wants. The old foreign policy consensus has shattered, he argues, and neither the Trump administration nor the Democratic establishment has produced a coherent replacement. He locates the most interesting thinking in the progressive wing of the Democratic Party, where he hopes the 2028 primary will force some of these hard questions into the open. Katherine Thompson, a Senior Fellow at the Cato Institute who previously served in the Pentagon and on Capitol Hill, brings a military-strategic lens. She makes a sharp case that the new National Defense Strategy, for all its imperfections, at least opens the door to an honest conversation about trade-offs — something Washington has been allergic to. If you're going to prioritize deterrence in the Indo-Pacific, she argues, you have to actually give things up elsewhere, and the Iran situation is making that tension impossible to ignore. Jonas Nahm, the Andrew W. Mellon Associate Professor at SAIS who served in the Biden administration, reframes economic competition with China in refreshingly concrete terms. Rather than abstract great-power framing, he identifies three specific buckets — affordability and energy, technological catch-up, and manufacturing competitiveness — where Chinese capacity could actually help solve American problems, if we had the political imagination to let it. And Leslie Vinjamuri, president and CEO of the Chicago Council on Global Affairs, brings striking new polling data showing a 40-percentage-point swing in American favorability toward China since 2024 — now at 53 percent — driven largely by Democrats but with movement among Republicans too. She situates this in the fading of pandemic-era hostility and the absence of sustained anti-China rhetoric from the current administration, and adds an invaluable perspective on how utterly confused America's allies are about what Washington actually expects of them. The conversation ranges across Taiwan and strategic ambiguity, whether allies arming up in the Indo-Pacific helps or hurts, the collapse of U.S. credibility on human rights, the future of dollar dominance, and whether the 2028 election will finally force a reckoning with these questions. It's a rich, candid discussion — and a reminder that the hardest debates in U.S.-China policy may not be about China at all. Panelists:— Matt Duss, Executive Vice President, Center for International Policy— Katherine Thompson, Senior Fellow, Cato Institute— Jonas Nahm, Andrew W. Mellon Associate Professor, Johns Hopkins SAIS— Leslie Vinjamuri, President and CEO, Chicago Council on Global Affairs Moderator: James Steinberg, Dean, Johns Hopkins School of Advanced International StudiesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this special “Ask the Expert” collaboration between The MOG Project and SRNA, Julia Lefelar and Dr. GG deFiebre welcomed Dr. Benjamin Greenberg of UT Southwestern, who answered questions from the audience. Dr. Greenberg reviewed major advances in MOG antibody disease research and diagnostic criteria [00:05:06]. He discussed efforts to predict relapse risk using sustained antibody positivity, demographic and clinical models, and immune-cell profiling studies [00:07:55]. Dr. Greenberg detailed controversies around low-positive antibody titers and how cell-based assays and dilution thresholds affect specificity [00:21:38]. He outlined concepts and progress in tolerance-inducing approaches such as Tregs and CAR T therapy, described differences from B-cell–depleting drugs like rituximab [00:26:32] Finally, Dr. Greenberg highlighted the satralizumab meteoroid trial and the ongoing cosMOG study of rozanolixizumab, emphasizing community engagement, registries, surveys, and trial participation to accelerate access and potential curative strategies [00:38:36]. You can learn more about The MOG Project here:https://mogproject.org/Benjamin M. Greenberg, MD, MHS is a Professor and the Cain Denius Scholar in Mobility Disorders in the Department of Neurology [ https://utswmed.org/why-utsw/departments/neurology/ ] at UT Southwestern Medical Center in Dallas, Texas. He currently serves as the Vice Chair of Translational Research and Strategic Initiatives for the Department of Neurology. He is also the interim Director of the Multiple Sclerosis Center [ https://utswmed.org/locations/aston/multiple-sclerosis-and-neuroimmunology-clinic/ ] and the Director of the Neurosciences Clinical Research Center. In addition, he serves as Director of the Transverse Myelitis and Neuromyelitis Optica Program and the Pediatric Demyelinating Disease Program at Children's Medical Center [ https://www.childrens.com/specialties-services/specialty-centers-and-programs/neurology/demyelinating-disease-program ].Dr. Greenberg earned his medical degree at Baylor College of Medicine before completing an internal medicine internship at Chicago's Rush Presbyterian-St. Luke's Medical Center. He performed his neurology residency at the Johns Hopkins School of Medicine. He also holds an M.H.S. in molecular microbiology and immunology from the Bloomberg School of Public Health, as well as a bachelor's degree in the history of medicine – both from Johns Hopkins. Prior to his recruitment to UT Southwestern in 2009, Dr. Greenberg was on the faculty of the Johns Hopkins Division of Neuroimmunology, serving as the Director of the Encephalitis Center and Co-Director of the nation's first dedicated Transverse Myelitis Center.Dr. Greenberg splits his clinical time between adult and pediatric patients at William P. Clements Jr. and Zale Lipshy University Hospitals, Parkland, and Children's Medical Center. His research focuses on better diagnosing, prognosticating, and treating demyelinating diseases and nervous system infections. He also coordinates clinical trials to evaluate new treatments to prevent neurologic damage and restore function to affected patients.00:00 Welcome01:44 Hosts and Guest Intro05:06 Research Buckets Overview07:55 Predicting Relapse Risk11:46 Tregs and Immune Brakes17:40 Attack Severity and Relapse19:24 MOGAD Criteria Updates21:38 Titers Explained Simply26:32 Targeting MOG Antibodies29:11 CAR T and Immune Reset32:39 When Criteria Changes33:52 Tolerance Research Boom34:48 From Animals to Trials37:17 Community Drives Progress38:36 Meteoroid and cosMOG Clinical Trials41:39 How These Drugs Work44:02 FDA Approval and Access45:49 Insurance Switch Concerns48:39 Rituximab Dosing Debate52:41 Why Antibodies Develop54:18 Future Attack Patterns55:47 CAR T Versus Rituximab57:10 Lab Research and Support01:00:51 Hope for a Cure01:02:14 Closing and Resources

In this episode, Anousha and Bright speak with Dr. Chloe Thio and Dr. David Thomas, academic medical researchers at the Johns Hopkins School of Medicine, about a new NIH grant supporting a Johns Hopkins–led consortium focused on finding a cure for hepatitis B. They discuss the goals of the $24 million award, the importance of collaborative science, and what this investment could mean for the future of hepatitis B research and for people living with the disease.Support the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook

Dr. Tasha Golden is a singer/songwriter turned behavioral scientist and a leading expert in creativity, leadership, and change. She has spoken and consulted for Google, the Mayo Clinic, the US Conference of Mayors, SXSW, and POLITICO, among many others—helping leaders and organizations link science and creative practice to drive innovation and growth. Dr. Golden was the first Director of Research for the International Arts + Mind Lab at Johns Hopkins School of Medicine, is adjunct faculty in the University of Florida's Center for Arts in Medicine, and lead author of Arts on Prescription: A Field Guide for US Communities. Named one of Fierce Pharma's "Fierce 50" for innovative work integrating arts and health, she publishes regularly in Psychology Today and her research has been featured in The Guardian, NPQ, and the CBC.

With the launch of a new journal, the American Diabetes Association (ADA) is also launching a brand new podcast: The Points of CARE, the official podcast of Diabetes, Obesity, and CardioMetabolic CARE. Join hosts Richard Beaser, MD and Jane Reusch, MD, as they highlight key research findings, clinical implications, and emerging themes across diabetes, obesity, and cardiometabolic health through interviews with journal authors and subject-matter experts. 2:30 After introducing his co-host, Jane Reusch, Beaser speaks with James Gavin, MD, PhD, of the Emory University School of Medicine and Naunihal Virdi, MD, MBA, FACP, of Abbott Diabetes Care. They are the authors of "Advancing Type 2 Diabetes Care: The Role of Continuous Glucose Monitoring in Noninsulin-Treated Patients," available for free at doi.org/10.2337/doc25-0058. 13:00 Our hosts are joined by Ivy Shi, MD and Dhruv Kazi, MD, MSc, MS, both of Beth Israel Deaconess Medical Center. They are the authors of "GLP-1 RA Eligibility in Reproductive-Age U.S. Women," available in the March/April issue of Diabetes, Obesity, and CardioMetabolic CARE. 19:40 Next, Eva Tseng, MD, MPH, associate professor of medicine at Johns Hopkins School of Medicine joins the podcast. Her article, "START Diabetes Prevention: A Multilevel Strategy for Primary Care Clinics," is available in the March/April issue of Diabetes, Obesity, and CardioMetabolic CARE. To learn more about Diabetes, Obesity, and CardioMetabolic CARE please visit diabetesjournals.org/docm-care. Thank you for listening, and don't forget to subscribe.

It's widely accepted that the post-WWII order has changed, but the question remains—what comes next? Political scientist Hal Brands maps out three possible scenarios in a cover essay for Foreign Policy's latest print issue and joins FP Live to discuss.  Brands is a professor of global affairs at the Johns Hopkins School of Advanced International Studies and the author of The Eurasian Century: Hot Wars, Cold Wars, and the Making of the Modern World. Hal Brands: Three Scenarios for a Post-Trump World Emma Ashford: A Better Trans-Atlantic Relationship Is Entirely Possible Sarang Shidore: Can Middle Powers Gel? Suzanne Nossel: What Would an Abundance Foreign Policy Look Like? Nils Gilman: Electrostates vs. Petrostates Learn more about your ad choices. Visit megaphone.fm/adchoices